Silymarin flavonoids and cyclosporin A: Effective co-therapy?
Authors
Abstract:
Milk thistle (Silybum marianum) is a native plant of Mediterranean Sea areas. Silymarin, an extract from its seeds, is used in various liver diseases for its hepatoprotective effects. It contains silymarin flavonoids (SF) such as silybin, silydianin and silychristin. Cyclosporin A (CsA) is widely used as an immunosuppressant in organ transplantations. Its other applications in many autoimmune diseases were demonstrated. Unfortunately CsA has obligatory negative effects: hepatotoxicity and nephrotoxicity. P-glycoprotein (Pgp) is the main target of CsA in plasma membrane and high affinity of CsA to this membrane transporter is connected with CsA toxicity. The aim of this study was to confirm the hypothesis, that SF compete with CsA for binding sites of membrane proteins in vitro and could protect liver cells against the entry of CsA toxic concentration. Rat hepatocytes were isolated by collagenase perfusion. They were incubated with silybin, silydianin, silychristin and CsA and 3H-labeled CsA was always added. The amounts of ligands bound in hepatocytes were estimated after vacuum filtration of cell suspension with help of radioligand depletion by using the scintillation method. Software GraphPad Prism4 was used for interpretation and statistic evaluation of data. All tested SF depleted 3H-CsA from its bound in hepatocytes. The mechanism of interaction between SF and CsA was evidently competitive. The highest affinity for the target protein has silychristin, IC50 being 0.14 ?M (95% confidence interval for log (IC50) [M] -7.03 to -6.69). IC50 for silybin and silydianin were estimated: 0.22 and 0.23 ?M, resp. (95% confidence intervals for log (IC50) [M] -6.91 to -6.42 and -6.93 to -6.33 resp.). The existence of competitive interaction between SF and CsA in hepatocyte membrane was confirmed and with high probability it is connected with one receptor, Pgp. It is possible to say, that the SF-protection of liver cells by patients with CsA-therapy could be effective.
similar resources
Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs
P-glycoprotein (P-gp), a well known efflux transporter in the blood brain barrier inhibits the uptake of substrate drugs into brain. The main aim of this study is to evaluate the effect of natural product based P-gp inhibitors on brain penetration of various CNS drugs which are P-gp substrates. In this study, we have evaluated the inhibitory effects of natural bioflavonoids (quercetin and silym...
full textEffects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
Flavonoids are constituents of fruits, vegetables, and plant-derived beverages, as well as components in herbal-containing dietary supplements. The objective of this investigation was to characterize the effect of flavonoids on P-glycoprotein (P-gp)-mediated cellular efflux and to determine the molecular mechanism(s) of the flavonoid-drug interaction. Studies were conducted in the sensitive and...
full textEffective intravenous cyclosporin therapy in a patient with severe Crohn's disease on parenteral nutrition.
We report a patient with severe Crohn's disease and the short bowel syndrome on parenteral feeding who was not responding to conventional therapy and underwent treatment with cyclosporin (CyA) given initially intravenously and subsequently orally in each of two courses. Plasma drug concentrations were largely kept within the therapeutic range but wide variability was observed on oral therapy. I...
full textCyclosporin A and Cyclosporin SDZ
Recent studies have shown that cyclosporin A (CsA) may affect ricin A-chain immunotoxin (RTA-IT) therapy. In this study, we evaluated the ability of CsA and its nonirnmunosuppressive analog. SDZ PSC 833, to enhance anti-CD5 T l O l RTA-ITS in vitro. Both 4 pmol/L CsA and 4 pmol/L SDZ PSC 833 significantly and specifically enhanced the cytotoxic activity of T101 RTA-IT on the human lymphoblastic...
full textPoly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer
The aim of this study was to address one of the major challenges of the actual era of nanomedicine namely, the bioavailability of poorly water soluble drugs such as Silymarin. We developed new, biodegradable, and biocompatible nanosized shuttles for Silymarin targeted delivery in colon-cancer cells. The design of these 100 nm sized carrier nanoparticles was based on natural polymers and their b...
full textMy Resources
Journal title
volume Volume 3 issue Supplement 2
pages 12- 12
publication date 2010-11-20
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023